Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0B6VN
|
||||
| Former ID |
DIB012521
|
||||
| Drug Name |
TZI-41078
|
||||
| Synonyms |
3,5-Di-tert-butyl-4-hydroxybenzophenone oxime
|
||||
| Indication | Arthritis [ICD9: 710-719; ICD10:M00-M25] | Phase 2 | [1] | ||
| Target and Pathway | |||||
| Target(s) | Lipoxygenase | Target Info | Modulator | [1] | |
| Cyclooxygenase | Target Info | Modulator | [1], [2] | ||
| References | |||||
| REF 1 | Hydroxylamine analogs of 2,6-di-t-butylphenols: dual inhibitors of cyclooxygenase and 5-lipoxygenase or selective 5-lipoxygenase inhibitors. Bioorg Med Chem. 1995 Apr;3(4):403-10. | ||||
| REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.